XML 20 R4.htm IDEA: XBRL DOCUMENT v3.25.3
CONSOLIDATED STATEMENTS OF INCOME (LOSS) - USD ($)
$ in Thousands
 12 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Revenue    
Rentals of medical equipment $ 100,108 $ 94,308
Sales of medical equipment and supplies 145,251 151,607
Total revenues 245,359 245,915
Cost of inventory sold 68,182 68,925
Operating expenses 125,457 122,542
Right-of-use operating lease amortization and interest 6,434 5,974
Depreciation 39,429 38,490
Amortization of intangible assets 6,053 6,091
Stock-based compensation 4,035 2,484
Acquisition-related costs 817 401
Gain on disposals of property and equipment (1,225) (107)
Operating income (loss) (3,823) 1,115
Interest expense 6,744 7,168
Interest income (467) (787)
Loss (gain) on foreign currency transactions 367 (43)
Share of loss in equity method investment 324 309
Change in fair value of derivative liability - interest rate swap (452) 1,122
Loss before income taxes (10,339) (6,654)
Provision for income taxes 241 109
Net loss before noncontrolling interest (10,580) (6,763)
Net income attributable to noncontrolling interest 121  
Net loss $ (10,701) $ (6,763)
Net income (loss) per share    
Basic loss per share $ (0.24) $ (0.16)
Diluted loss per share $ (0.24) $ (0.16)
Weighted average number of common shares outstanding:    
Basic (in shares) 43,291 42,501
Diluted (in shares) 43,291 42,501